In an unusual achievement, three early career scientists from the lab of Prof. Marie José Kersten received Abstract Achievement Awards during the annual congress of the American Society of Hematology (ASH).

Every year, the American Society of Hematology organizes an enormous scientific conference where leading scientists from all over the world (~25,000) come together to present and discuss the latest research findings in the field of hematology. The most recent ASH Annual Meeting and Exposition was held in in Atlanta, Georgia, USA.

Abstract Achievement Award

The ASH Abstract Achievement Awards are presented to early career scientists who have submitted a high scoring abstract. From the research group of Prof. Marie José Kersten, Anne Spanjaart, Karima Amaador and Julia Driessen all received the award for the following research presentations:

Anne Mea Spanjaart: Poor Outcome of Patients with COVID-19 after CAR T-Cell Therapy for B-Cell Malignancies: Results from a Multicenter Study on Behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group

Karima Amaador: Evaluating Patients' Preferences Regarding Treatment Options for Waldenström’s Macroglobulinemia, a Discrete-Choice-Experiment

Julia Driessen: Effect of Brentuximab Vedotin Addition to Chemotherapy and Prognostic Factors in Patients with Relapsed/Refractory Hodgkin Lymphoma: A Large Multi-Trial Analysis Based on Individual Patient Data

Congratulations Anne, Karima and Julia!

Hat-trick III

Marie José Kersten also noted that “By the way, Anne, together with hematology fellow Fleur van der Valk, is also the first author of our 3rd New England Journal of Medicine (NEJM) paper in a month.” This third hat-trick is in addition to the hat-trick reported in the last newsletter for the Department of Hematology that included two papers by Prof. Kersten and one by Dr. Erfan Nur.

Read the paper: Clinical Problem-Solving / “Confused about Confusion” in NEJM - impact factor: 91.24 - here.

For more information, contact Prof. Marie José Kersten.